Q: What therapeutic areas does Abramson Cancer Center at Penn Medicine research focus on?

Abramson Cancer Center at Penn Medicine clinical trials span Myeloma Multiple, Lymphoma, Non-Hodgkin, Relapsed Diffuse Large B Cell Lymphoma, Refractory Diffuse Large B-cell Lymphoma, High-grade B-cell Lymphoma, and additional conditions. The research pipeline includes Phase 2, Phase 1, EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

Question 1

How many clinical trials has Abramson Cancer Center at Penn Medicine sponsored?

Accepted Answer

ClinicalMetric currently tracks 14 clinical trials sponsored by Abramson Cancer Center at Penn Medicine, of which 14 are actively recruiting participants. These trials cover conditions including Myeloma Multiple, Lymphoma, Non-Hodgkin, Relapsed Diffuse Large B Cell Lymphoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

Question 2

What therapeutic areas does Abramson Cancer Center at Penn Medicine research focus on?

Accepted Answer

Abramson Cancer Center at Penn Medicine is a clinical research sponsor with 14 registered studies on ClinicalTrials.gov, of which 14 are actively recruiting participants. Research covers conditions including Myeloma Multiple, Lymphoma, Non-Hodgkin, Relapsed Diffuse Large B Cell Lymphoma, Refractory Diffuse Large B-cell Lymphoma.

The trial portfolio spans Phase 2, Phase 1, EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Question 3

How do I participate in a Abramson Cancer Center at Penn Medicine clinical trial?

Accepted Answer

To participate in a Abramson Cancer Center at Penn Medicine trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Abramson Cancer Center at Penn Medicine trials with current recruitment status updated daily.

Abramson Cancer Center at Penn Medicine

Frequently Asked Questions — Abramson Cancer Center at Penn Medicine

Clinical Trials by Abramson Cancer Center at Penn Medicine

Limited-duration Teclistamab

Epcoritamab-CAR T Cells for Large B-cell Lymphomas

Noncombustible Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers

Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk

Hypofractionated WPPT With HDR Boost

FTT PET/CT in Pancreatic Neuroendocrine Tumors

Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

Polygenic Risk Scores and Multi-cancer Early Detection for Ovarian Cancer

Consolidative Metastasis and Primary Directed Therapy (MPDT) for Renal Cell Carcinoma (RCC)

FES BPET-DBT in Newly Diagnosed Breast Cancer

Physiologic MR Imaging of Salivary Gland Tumors

The Radiation Oncology Registry and Biosample Repository

Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES